The splice variant Ehm2/1 in breast cancer MCF-7 cells interacted with β-catenin and increased its localization to plasma membrane
Hefen Yu(Capital University), Wen G. Jiang(Shandong Center for Disease Control and Prevention)
Cited by 2
Related Papers
Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical Development
|Journal of Medicinal Chemistry|2014|151
The mRNA expression of SATB1 and SATB2 in human breast cancer
|Cancer Cell International|2009|103
Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.
|PubMed|2011|101